良性前列腺增生合并膀胱结石的危险因素分析及列线图预测模型的建立
Analysis of Risk Factors and Establishment of a Nomogram Prediction Model for Benign Prostatic Hyperplasia with Bladder Stones
DOI: 10.12677/acm.2025.15103013, PDF,    科研立项经费支持
作者: 胡智超, 伍晓雅, 周若晨, 陆兆祥*:安徽医科大学第四附属医院泌尿外科,安徽 巢湖
关键词: 良性前列腺增生膀胱结石危险因素列线图Benign Prostatic Hyperplasia Bladder Stones Risk Factors Nomogram
摘要: 目的:探索良性前列腺增生(Benign prostatic hyperplasis, BPH)患者合并膀胱结石的相关危险因素,并建立良性前列腺增生合并膀胱结石的列线图预测模型。方法:对我院泌尿外科2021年1月至2022年12月收治的395例因BPH接受手术治疗的患者进行临床回顾性分析,按7:3比例随机分为训练集(n = 276)和验证集(n = 119),训练集根据是否合并膀胱结石将患者分为膀胱结石组(n = 98)和无膀胱结石组(n = 178)。比较训练集中两组患者的病历资料,通过单因素及多因素Logistic回归筛选出BPH患者结石形成的独立危险因素,并采用R软件建立膀胱结石的列线图预测模型并验证。结果:多因素Logistic回归分析结果显示,血尿酸(OR = 1.005, 95% CI: 1.002~1.007)、尿比重(OR = 3.754, 95% CI: 2.004~7.153)、尿白细胞(OR = 2.491, 95% CI: 1.130~4.750)、尿培养(OR = 2.998, 95% CI: 1.223~7.707)是BPH并发膀胱结石的独立危险因素。将多因素分析结果纳入模型构建,训练集和验证集的校正曲线显示实际值和预测值基本吻合;采用Bootstrap自抽样法对模型进行内部验证,训练集和验证集的一致性指数(C-index)分别为0.709、0.773;本研究Hosmer-Lemeshow拟合优度检验P = 0.131 (P > 0.05),提示预测模型拟合度好。训练集的受试者工作特征曲线的曲线下面积为0.720 (95% CI: 0.652~0.788),灵敏度和特异度分别是61.2%和83.1%,验证集的受试者工作特征曲线的曲线下面积为0.792 (95% CI: 0.720~0.888),灵敏度和特异度分别是64.1%和83.8%;决策曲线分析显示BPH患者合并膀胱结石的列线图模型的临床预测效用较好。结论:血尿酸、尿比重、尿白细胞、尿培养是BPH合并膀胱结石的独立危险因素,该列线图预测模型具有较高准确度,对临床患者的个体化预防及治疗具有一定的指导价值。
Abstract: Objective: To explore the related risk factors for benign prostatic hyperplasia (BPH) patients complicated with bladder stones and establish a nomogram prediction model for BPH complicated with bladder stones. Methods: A retrospective clinical analysis was conducted on 395 patients with benign prostatic hyperplasia (BPH) who underwent surgical treatment in the department of urology from January 2021 to December 2022. The patients were randomly divided into a training set (n = 276) and a validation set (n = 119) at a ratio of 7:3. In the training set, patients were categorized into a bladder stone group (n = 98) and a non-bladder stone group (n = 178) based on the presence or absence of bladder stones. The medical records of the two groups in the training set were compared. Univariate and multivariate Logistic regression analyses were performed to identify independent risk factors for stone formation in BPH patients. A nomogram prediction model for bladder stones was then established and validated using R software. Results: Multivariate Logistic regression analysis revealed that serum uric acid (OR = 1.005,95% CI: 1.002~1.007), urine specific gravity (OR = 3.754, 95% CI: 2.004~7.153), urinary leukocytes (OR = 2.491, 95% CI: 1.130~4.750) and urine culture results (OR = 2.998, 95% CI: 1.223~7.707) are independent risk factors for bladder calculi in patients with benign prostatic hyperplasia (BPH). The results of the multivariate analysis were incorporated into the model construction. The calibration curves of the training and validation sets demonstrated a good agreement between the actual and predicted values. Internal validation of the model was conducted using the Bootstrap resampling method, with consistency indices (C-index) of 0.709 and 0.773 for the training and validation sets, respectively. The Hosmer-Lemeshow goodness-of-fit test in this study yielded a P-value of 0.131 (P > 0.05), indicating a good fit of the prediction model. The area under the receiver operating characteristic curve (AUC) was 0.720 (95% CI: 0.652~0.788) for the training set, with a sensitivity and specificity of 61.2% and 83.1%, respectively. For the validation set, the AUC was 0.792 (95% CI: 0.720~0.888), with a sensitivity and specificity of 64.1% and 83.8%, respectively. Decision curve analysis demonstrated that the nomogram model for BPH patients complicated with bladder stones had good clinical predictive utility. Conclusions: Serum uric acid, urine specific gravity, urine white blood cells, and urine culture are independent risk factors for BPH complicated with bladder stones. The nomogram prediction model exhibits high accuracy and has certain guiding value for the individualized prevention and treatment of clinical patients.
文章引用:胡智超, 伍晓雅, 周若晨, 陆兆祥. 良性前列腺增生合并膀胱结石的危险因素分析及列线图预测模型的建立[J]. 临床医学进展, 2025, 15(10): 2299-2310. https://doi.org/10.12677/acm.2025.15103013

参考文献

[1] 宋爽, 蒋运兰, 李滔, 等. 中国成年男性良性前列腺增生发生率的Meta分析[J]. 预防医学情报杂志, 2024, 40(11): 1463-1472.
[2] Philippou, P., Moraitis, K., Masood, J., Junaid, I. and Buchholz, N. (2012) The Management of Bladder Lithiasis in the Modern Era of Endourology. Urology, 79, 980-986. [Google Scholar] [CrossRef] [PubMed]
[3] 雷俊, 田野, 罗光恒, 等. 改良膀胱出口梗阻指数在良性前列腺增生症中与下尿路症状、尿动力学及手术效果相关性研究[J]. 贵州医药, 2021, 45(7): 1090-1092.
[4] Skolarikos, A., Geraghty, R., Somani, B., et al. (2025) European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis. European Urology, 88, 64-75.
[5] Wang, W., Guo, Y., Zhang, D., Tian, Y. and Zhang, X. (2015) The Prevalence of Benign Prostatic Hyperplasia in Mainland China: Evidence from Epidemiological Surveys. Scientific Reports, 5, Article No. 13546. [Google Scholar] [CrossRef] [PubMed]
[6] Dhondup, T., Kittanamongkolchai, W., Vaughan, L.E., Mehta, R.A., Chhina, J.K., Enders, F.T., et al. (2018) Risk of ESRD and Mortality in Kidney and Bladder Stone Formers. American Journal of Kidney Diseases, 72, 790-797. [Google Scholar] [CrossRef] [PubMed]
[7] 张家铭, 罗康. 高龄前列腺增生患者膀胱结石的影响因素及其风险模型[J]. 现代泌尿外科杂志, 2022, 27(2): 144-147.
[8] 林艳. 良性前列腺增生患者合并形成膀胱结石的危险因素调查分析[J]. 护理实践与研究, 2021, 18(9): 1313-1316.
[9] 陈烨辉, 林婷婷, 李晓东, 等. 良性前列腺增生患者并发膀胱结石的危险因素分析[J]. 临床泌尿外科杂志, 2018, 33(12): 965-967, 971.
[10] 逄瑷博, 凌存保, 黄薇, 等. 良性前列腺增生患者膀胱结石的影响因素分析[J]. 标记免疫分析与临床, 2022, 29(10): 1643-1647, 1653.
[11] Zhu, C., Ma, L., Chen, X., Zhou, Y., Wei, Y., Zhou, P., et al. (2025) Bladder Stone Composition in Jiangsu Region of China: Results from 421 Stone Analyses. Urologia Internationalis. [Google Scholar] [CrossRef] [PubMed]
[12] Wiederkehr, M.R. and Moe, O.W. (2011) Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder. Clinical Reviews in Bone and Mineral Metabolism, 9, 207-217. [Google Scholar] [CrossRef] [PubMed]
[13] Abou-Elela, A. (2017) Epidemiology, Pathophysiology, and Management of Uric Acid Urolithiasis: A Narrative Review. Journal of Advanced Research, 8, 513-527. [Google Scholar] [CrossRef] [PubMed]
[14] Mao, W., Zhang, H., Xu, Z., Geng, J., Zhang, Z., Wu, J., et al. (2021) Relationship between Urine Specific Gravity and the Prevalence Rate of Kidney Stone. Translational Andrology and Urology, 10, 184-194. [Google Scholar] [CrossRef] [PubMed]
[15] 高英力. 良性前列腺增生症并发膀胱结石老年男性膀胱出口梗阻预测模型的建立与验证[D]: [博士学位论文]. 上海: 上海交通大学, 2020.
[16] Song, Y., Gu, Y., Guo, H., Yang, H., Wang, X., Wu, H., et al. (2023) Association between Neutrophil-to-Lymphocyte Ratio and Benign Prostatic Hyperplasia: Results from the TCLSIH Cohort Study. Journal of Inflammation Research, 16, 4857-4866. [Google Scholar] [CrossRef] [PubMed]
[17] Kang, J.Y., Choi, J.D., Cho, J.M., Yoo, T.K., Park, Y.W. and Lee, J.H. (2021) Association of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Lymphocyte-to-Monocyte Ratio with Benign Prostatic Hyperplasia: A Propensity Score-Matched Analysis. Urologia Internationalis, 105, 811-816. [Google Scholar] [CrossRef] [PubMed]
[18] Wigner, P., Grębowski, R., Bijak, M., Szemraj, J. and Saluk-Bijak, J. (2021) The Molecular Aspect of Nephrolithiasis Development. Cells, 10, Article 1926. [Google Scholar] [CrossRef] [PubMed]
[19] Huang, K., Peng, Z., Zha, C., Li, W., Deng, G., Chen, X., et al. (2024) Inflammatory Factors and the Risk of Urolithiasis: A Bidirectional Mendelian Randomization Study. Frontiers in Medicine, 11, Article 1432275. [Google Scholar] [CrossRef] [PubMed]
[20] Razi, A., Ghiaei, A., Dolatabadi, F.K. and Haghighi, R. (2024) Unraveling the Association of Bacteria and Urinary Stones in Patients with Urolithiasis: An Update Review Article. Frontiers in Medicine, 11, Article 1401808. [Google Scholar] [CrossRef] [PubMed]
[21] Trinchieri, A. (2014) Urinary Calculi and Infection. Urologia Journal, 81, 93-98. [Google Scholar] [CrossRef] [PubMed]
[22] Parsons, C.L., Stauffer, C., Mulholland, S.G. and Griffith, D.P. (1984) Effect of Ammonium on Bacterial Adherence to Bladder Transitional Epithelium. Journal of Urology, 132, 365-366. [Google Scholar] [CrossRef] [PubMed]
[23] Lee, W., Lam, S., Zhang, Y., Yang, R. and Cai, J. (2022) Review of Methodological Workflow, Interpretation and Limitations of Nomogram Application in Cancer Study. Radiation Medicine and Protection, 3, 200-207. [Google Scholar] [CrossRef